Merck & Co Inc (MRK)

MRK (NYSE:Drugs) EQUITY
$57.75
pos +0.00
+0.00%
Today's Range: 57.63 - 58.23 | MRK Avg Daily Volume: 11,346,700
Last Update: 03/27/15 - 4:00 PM EDT
Volume: 0
YTD Performance: 1.69%
Open: $0.00
Previous Close: $57.60
52 Week Range: $52.49 - $63.62
Oustanding Shares: 2,838,192,933
Market Cap: 163,479,912,941
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 7 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.08 2.00 2.00 2.00
Latest Dividend: 0.45
Latest Dividend Yield: 3.12%
Dividend Ex-Date: 03/12/15
Price Earnings Ratio: 14.15
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
14.15 14.10 27.26
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-0.05% 3.62% 48.84%
GROWTH 12 Mo 3 Yr CAGR
Revenue -4.10 -0.12 -0.04
Net Income 164.20 0.87 0.23
EPS 176.90 1.02 0.26
Earnings for MRK:
EBITDA 13.37B
Revenue 42.24B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $0.77 $0.80 $3.40 $3.82
Number of Analysts 7 7 10 10
High Estimate $0.82 $0.86 $3.48 $4.10
Low Estimate $0.73 $0.75 $3.28 $3.45
Prior Year $0.88 $0.85 $3.49 $3.40
Growth Rate (Year over Year) -12.18% -5.71% -2.55% 12.44%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Mar 25, 2015 | 4:13 PM EDT

We won't get a real bottom until they happen.

By

Jim Cramer

 | Mar 24, 2015 | 6:29 PM EDT

Good buys kept getting overlooked.

updateBarclays Healthcare Conf.

Mar 11, 2015 | 7:52 AM EDT

Barclays Healthcare Conference

By

Gary Berman

 | Mar 9, 2015 | 9:30 AM EDT

The shares are inside the bounce zone.

updateCowen Healthcare Conf.

Mar 3, 2015 | 5:09 AM EST

Cowen Health Care Conference (Day 2 of 3) - 03/02/15 - 03/04/15 Boston, MA

bearishMerck estimates, target lowered at BMO

Feb 5, 2015 | 8:00 AM EST

MRK estimates were cut through 2016, BMO Capital said. Company is facing significant growth headwinds. Market Perform rating and new $60 price target. 

By

Jim Cramer

 | Jan 15, 2015 | 3:40 PM EST

Use the overall weakness to pick up the America First stocks.

By

Jim Cramer

 | Jan 12, 2015 | 11:19 AM EST

Low P/E multiples just aren't any protection.

By

Christopher Versace

 | Jan 12, 2015 | 9:59 AM EST

Watch the share count when looking at earnings.

By

David Katz

 | Jan 6, 2015 | 9:00 AM EST

Try these stocks for dividend income instead.

Cover story in Barrons: "JPMorgan Rising" - JPM was added to my Best Ideas List and "Trade...
Darden Restaurants' (DRI) CFO sold 66,863 shares on March 24, 2015 for an average price of...
We did not end up holding the pullback to the last time/price low in NFLX. I have run som...
The Biotech iShares (IBB) fund closed up nearly 2% on the day, but was down over 5% on th...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.